S100/SOX10-positive uterine sarcoma with ERBB2/ERBB3 mutation is a newly recognized and highly aggressive subtype of uterine sarcoma characterized by aberrant HER2 pathway activation and neural crest-like immunophenotype [135,136,137]. Here, ERBB3 is linked to uterine corpus sarcoma.